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Abstract
Upon erythropoietin (Epo) engagement, Epo-receptor (R) homodimerizes to activate JAK2 and Lyn, which phosphorylate
STAT5. Although recent investigations have identified key negative regulators of Epo-R signaling, little is known about the
role of membrane localization in controlling receptor signal fidelity. Here we show a critical role for membrane raft (MR)
microdomains in creation of discrete signaling platforms essential for Epo-R signaling. Treatment of UT7 cells with Epo
induced MR assembly and coalescence. Confocal microscopy showed that raft aggregates significantly increased after Epo
stimulation (mean, 4.361.4(SE) vs. 25.663.2 aggregates/cell; p#0.001), accompanied by a .3-fold increase in cluster size
(p#0.001). Raft fraction immunoblotting showed Epo-R translocation to MR after Epo stimulation and was confirmed by
fluorescence microscopy in Epo stimulated UT7 cells and primary erythroid bursts. Receptor recruitment into MR was
accompanied by incorporation of JAK2, Lyn, and STAT5 and their activated forms. Raft disruption by cholesterol depletion
extinguished Epo induced Jak2, STAT5, Akt and MAPK phosphorylation in UT7 cells and erythroid progenitors. Furthermore,
inhibition of the Rho GTPases Rac1 or RhoA blocked receptor recruitment into raft fractions, indicating a role for these
GTPases in receptor trafficking. These data establish a critical role for MR in recruitment and assembly of Epo-R and signal
intermediates into discrete membrane signaling units.
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Introduction
Erythropoietin (Epo) is the principal regulator of red blood cell
production [1,2]. Upon Epo binding to its cognate receptor (R),
the Epo-R homodimerizes to initiate activation of the non-
receptor tyrosine kinases JAK2 and Lyn, which in turn
phosphorylate the receptor’s cytoplasmic tail and the signal
transducer and activator of transcription 5 (STAT5) [1,2,3].
Dimerization of phospho (P)-STAT5 enables its translocation to
the nucleus and binding to target gene promoters, ultimately
promoting the expansion, differentiation, and survival of red blood
cell precursors [1,2,3]. The Epo signaling pathway is regulated by
a balance of phosphatase and kinase activities [3]. Lyn kinase has
been shown to enhance proliferation of erythroid progenitors by
increasing colony forming capacity and promoting progenitor
maturation [4,5]. Loss of Lyn inhibits activation of STAT5
presumably through activation of negative regulatory phospha-
tases, such as Src homology domain-containing phosphatase-1
(SHP-1), SHP-2, and Src homology-2 domain-containing inositol
5-phosphatase 1 (SHIP-1) [6,7]. Furthermore, association of Lyn
with and phosphorylation of Epo-R and STAT5 promotes
activation of downstream signaling [8]. Although the signaling
cascade initiated by Epo and the balance of phosphatase and
kinase activity has been well studied, the role of receptor
localization in the plasma membrane and its effect on signal
integrity has not been investigated.
The plasma membrane of hematopoietic cells contains
sphingolipid and cholesterol enriched microdomains called lipid
or membrane rafts [9,10]. Lipid rafts represent hydrophobic,
detergent-insoluble membrane fractions enriched in glycolipids
and cholesterol. As a consequence, lipid rafts migrate to low
density matrices upon gradient centrifugation allowing the
isolation of raft membrane fractions and associated proteins
[11,12]. Lipid rafts are specialized membrane microdomains that
cluster signaling intermediates to create focused signaling plat-
forms that facilitate receptor-induced activation of signal trans-
duction molecules. Rafts rapidly coalesce to form aggregates in
response to cytokine stimulation or integrin engagement to
optimize signal transduction [12,13,14,15]. The clustering of rafts
serves to expose proteins to a membrane environment enriched in
components that amplify the signaling cascade, including kinases,
scaffold and adaptor proteins, substrates as well as redistribution of
regulatory phosphatases [12,13,14,15]. Recent investigations have
shown that raft microdomains have a critical role in T-cell
receptor, c-kit and integrin signaling, protein trafficking, endocy-
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tosis, as well as many other diverse cellular functions
[12,16,17,18,19,20,21]. In this study, we examined the role of
lipid raft recruitment in Epo-R signaling, receptor interaction with
signaling intermediates and Epo-R signal integrity.
Results
Epo induces raft formation and aggregation
Lipid raft microdomains are characterized by their insoluble
nature in non-ionic detergents as well as the presence of the
constituent ganglioside GM-1 and double acylated proteins such as
the Src-family kinase and Lyn kinase. We first investigated
whether Epo affects membrane raft assembly or raft coalescence
by assessing changes in membrane fraction distribution of GM-1
and Lyn kinase after Epo stimulation. Dot blot analysis of
fractionated UT7 cell lysates revealed a greater than 5-fold
increase of GM-1 in the detergent insoluble raft membrane
fractions (fractions 1 and 2) after Epo exposure (Fig. 1A),
accompanied by increased raft partitioning of Lyn kinase
(Fig. 1B). To verify that the detergent insoluble fractions
represented lipid rafts, we treated cells with a known membrane
cholesterol chelating agent, methyl-b-cyclodextrin (MBCD), to
disrupt raft integrity, and examined GM-1 and Lyn partitioning in
membrane fractions. Treatment with MBCD abrogated partition-
ing of either GM-1 or Lyn into the detergent-insoluble membrane
fractions, consistent with lipid raft distribution (Figs. 1A and B).
In T-lymphocytes, clustering of lipid rafts is an essential step in
the formation of an immune synapse in response to antigen
activation of the T-cell receptor [19]. To determine if Epo
promotes raft coalescence, we quantitated changes in GM-1
labeled clusters after growth factor treatment. Raft accumulation
in UT7 cells after Epo stimulation increased (Fig. 1C), accompa-
nied by a significant increase in the mean number of raft
aggregates (4.361.4 per cell in untreated controls compared to
25.663.2 aggregates per cell after Epo stimulation) (Fig. 1D;
p#0.001). The size of raft aggregates also increased after Epo
treatment, with a 3.3360.11 fold increase compared to unstimu-
lated controls (p#0.001). To verify that the observed changes in
raft dynamics in UT7 cells extends to normal erythroid
progenitors, we assessed raft assembly in bone marrow erythroid
bursts derived from a normal donor. BFU-E were isolated by
pipetting colonies grown in methylcellulose assays after 14 days
incubation. Immunofluorescence staining for GM-1 (Fig. 1E)
showed that mean raft fluorescence intensity in primary erythroid
progenitors increased 58.4% from 72.79614/cell in unstimulated
cells to 115.27614.22 after Epo treatment (p= 0.01).
Epo-R co-localizes within lipid rafts
Recruitment of the T-cell receptor into lipid rafts is a dynamic
process, triggered by major histocompatability antigen engage-
ment [12]. To determine if the Epo-R co-localizes within raft
microdomains and is influenced by ligand engagement, we
assessed Epo-R localization by confocal microscopy with and
without Epo stimulation. Epo-R rapidly co-localized with GM-1 in
UT7 cells after Epo stimulation (Fig. 2A, rows 1 and 2).
Translocation of the Epo-R to membrane rafts after Epo
treatment was also confirmed in primary bone marrow erythroid
bursts (Fig. 2A, rows 3 and 4). In addition to immature erythroid
progenitors such as burst forming units (BFU-E), colocalization of
Epo-R in GM-1 raft clusters was also observed in more mature,
enucleated erythroid cells after Epo stimulation (Fig. 2A, bottom
row). To further illustrate the recruitment of receptor to the rafts,
we utilized the power of 3D rendering. Figure 2B is a represen-
tative micrograph of an unstimulated (left) and stimulated (right)
UT7 cell in which the number of rafts is increased (red) as well as
the recruitment of the receptor (green) to these domains. The
bottom row in Figure 2B utilizes volume rendering to emphasize
the colocalization (yellow) of the rafts and receptor on the cell
surface. We used the Pearson’s coefficient to quantitate the percent
of colocalization in primary BFU-E cells where there is a significant
increase in colocalization after Epo stimulation (p = 0.02) (Fig. 2C).
Epo-R membrane dynamics were further investigated by western
blot analysis of membrane fractions from UT7 cell lysates isolated
by gradient centrifugation. Raft (R) and non-raft (NR) fractions
were pooled and separated by SDS-PAGE. Epo-R was not
detected in lipid rafts from unstimulated cells, but was restricted to
the membrane and cytosol fractions. After 10 min of Epo
exposure, the receptor translocated into raft fractions (Fig. 3A),
confirming that Epo-R ligand engagement triggers redistribution
of the receptor to membrane raft microdomains. To confirm Epo-
R specificity of antibody immuno-reactivity [22,23,24], receptor
translocation was confirmed with several commercially available
antibodies, including the Abcam mouse mAb (MM-0031-6G7)
(Cambridge, MA), the Abcam goat polyclonal Epo-R antibody,
and the monoclonal A82 Epo-R antibody generously provided by
Amgen (Thousand Oaks, CA) [25], each of which confirmed our
findings of ligand induced raft translocation. Densitometry analysis
of 2 independent experiments using all 4 of the above mentioned
antibodies is presented in Figure 3A. Based on recent investiga-
tions validating the specificity of the Santa Cruz Biotechnology
(Santa Cruz, CA) Epo-R antibody (M-20), this antibody was used
preferentially in subsequent experiments [26]. Furthermore,
although Epo signaling is known to diminish after 10 minutes,
we next investigated an extended range of intervals after Epo
stimulation to discern the rapidity of receptor translocation into
raft fractions (Fig. 3B). Epo-R was recruited into the raft fractions
within 1 minute of growth factor exposure, reaching a peak at
10 minutes, followed by gradual redistribution that was completed
by 60 minutes.
Epo engagement initiates recruitment of signaling
intermediates into lipid raft fractions
Because Epo-R was recruited into membrane rafts after growth
factor stimulation, we investigated subcellular localization of
corresponding signal effectors to determine if receptor trans-
location was coordinated with effector molecules to form discrete
membrane platforms for receptor signaling. Immunostaining of
membrane fractions for STAT5, JAK2, Lyn, and CD45 showed
that Lyn and CD45 were constitutively localized in raft fractions in
unstimulated cells, whereas JAK2 was absent with minimal
detection of STAT5 (Fig. 3C). After Epo stimulation, both JAK2
and STAT5 (principal Epo signaling proteins) translocated into
raft fractions accompanied by an increase in Lyn kinase. However,
CD45, a receptor tyrosine phosphatase and key negative regulator
of Epo-R signaling, was excluded from raft fractions and re-
partitioned entirely into non-raft fractions (Fig. 3C). The
differential localization of CD45 after Epo stimulation suggests
that growth factor activation initiates a controlled process of raft
assembly and aggregation favoring the recruitment of effector
molecules supporting receptor signal transduction. Furthermore,
we were able to show that the activated forms of both Jak2 and
Stat5, as well as the alternative Epo signaling pathway, MAPK
proteins, accompanied Epo-R in raft fractions after growth factor
stimulation (Fig. 3D).
Lipid rafts are required for Epo-R signaling
Given that Epo-R activation triggers formation of rafts enriched
in signal effectors, we next investigated whether rafts are necessary
Epo-R Signaling Is Membrane Raft Dependent
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for receptor signaling by way of raft microdomain disruption.
Cholesterol depletion of UT7 cell membranes with methyl-b-
cyclodextrin (MBCD) disrupted raft integrity and completely
extinguished Epo induced phosphorylation of STAT5, the
primary downstream transcription factor (Fig. 4A). To determine
if secondary Epo signaling pathways were also affected by MBCD
treatment, we probed UT7 cells for P-MAPK (mitogen-activated
protein kinase). Indeed, pretreatment of cells with MBCD
abrogated activation of MAPK with Epo stimulation. The
PI3K/Akt pathway is not activated by Epo in UT7 cells,
therefore, to investigate effects on this signaling pathway, we
utilized the UT7/Epo cell line which displays Akt activation upon
Epo stimulation (Fig. 4B). Pretreatment with MBCD completely
extinguished activation of Akt by Epo, thereby confirming that all
Epo signaling pathways are impaired by raft disruption. To verify
that MBCD treatment only affected signaling pathways localized
to lipid rafts, we treated UT7 cells with the cell permeable phorbol
12-myristate 13-acetate (PMA), which is not directly dependent on
membrane receptor activation, and induces UT7 differentiation in
part through the activation of MAPK. Pretreatment of UT7 cells
with MBCD prior to PMA stimulation did not effect activation of
MAPK as evidenced by enzyme phosphorylation (Fig. 4C). These
data indicate that lipid raft integrity is essential for Epo-R
signaling, whereas non-receptor or non-raft signaling pathways are
preserved and independent of raft integrity. To confirm that
abrogation of Epo-R/STAT5 signaling by MBCD is not specific
to this compound, we repeated the above experiment using the
cholesterol intercalating agent, nystatin, a less effective but
alternative method to interfere with raft assembly and dynamics.
Similar to our findings with MBCD, treatment with nystatin
decreased STAT5 phosphorylation in response to Epo stimulation
(Fig. 4D); providing further support for the importance of lipid
rafts in Epo-R signal transduction.
Raft disruption attenuates Epo-induced P-STAT5
induction in primary erythroid progenitors
To confirm raft integrity is critical to Epo-R signaling in
primary erythroid progenitors, we next assessed the effect of raft
disruption by MBCD on Epo induced STAT5 phosphorylation by
flow cytometry in bone marrow derived erythroid precursors from
Figure 1. Epo stimulation induces raft formation and aggregation. (A) Dot blot detection of GM-1 in UT7 cell lysates in non-raft (fractions 5,
6) and raft fractions (fraction 2) with corresponding densitometry value in controls, and after Epo or MBCD treatment. Representative blot of at least
three independent experiments. (B) Western immunoblot of Lyn in raft (R) (fractions 1–2) and non-raft (NR) fractions (fractions 4–6). Treatment with
Epo increased Lyn kinase incorporation into raft fractions, whereas raft disruption by cholesterol depletion with MbCD precluded Lyn incorporation.
Representative western of at least three independent experiments. (C) Immunofluorescence of UT7 cells showing an increase in raft (red)
accumulation after Epo exposure. (D) Immunofluorescence of UT7 cells before and after Epo stimulation showing increased raft aggregates (red) in
the plasma membrane and corresponding quantitation. (E) Immunofluorescence of primary erythroid bursts showing an increase in cellular
membrane raft fluorescence intensity (red). Immunoflorescence experiments were repeated at least 3 times, representative micrographs displayed.
doi:10.1371/journal.pone.0034477.g001
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a normal donor. After a 2 h starvation, BM-MNCs were
pretreated with MBCD either with or without Epo. Cells were
permeabilized and stained with antibodies to CD71, CD45, and
phospho-STAT5. Epo-responsive erythroid progenitors were
identified by gating on the CD45 dim population of CD71+ cells
(Fig. 5A), and phospho-STAT5 mean fluorescent intensity (MFI)
was determined (Fig. 5B). Treatment with MBCD significantly
decreased STAT5 phosphorylation in response to Epo stimulation
(Fig. 5B; P= 0.01). Flow histograms show a marked shift consistent
with a marked reduction in phospho-STAT5 MFI (Fig. 5C). These
findings confirm that membrane raft integrity is critical to the
fidelity of Epo-R signaling in primary erythroid precursors.
Recruitment of Epo-R into lipid rafts is abrogated by Rac1
and RhoA inhibition
Rho GTPases are key regulators of intracellular actin dynamics,
and are involved in T-cell receptor trafficking into lipid rafts upon
receptor stimulation [19]. We therefore investigated whether
GTPases were also involved in Epo-R recruitment into membrane
rafts after Epo stimulation. UT7 cells were pretreated with a Rac1
inhibitor prior to Epo stimulation, demonstrating that inhibition of
Rac1 suppressed recruitment of the receptor into raft fractions
(Fig. 6A). We next investigated the effects of RhoA family GTPase
inhibition by pretreating cells with the Rho-associated protein
kinase, ROCK, inhibitor, Y-27632; again showing that Epo-R
recruitment was blocked (Fig. 6B). These findings suggest that
Rac1 and RhoA GTPase activation is critical in the redistribution
of receptor into membrane fraction upon ligand binding.
Discussion
To our knowledge, these are the first data to provide evidence
that the Epo-R translocates into lipid raft microdomains of the
plasma membrane upon ligand engagement (Fig. 2). Moreover,
receptor recruitment into rafts appears necessary for Epo-R signal
fidelity and consequent activation of STAT5. In unstimulated
cells, the Epo-R resided largely in non-raft membrane fractions,
Figure 2. Epo-R co-localizes with lipid rafts. (A) Confocal immunofluorescence of cells untreated or after Epo stimulation, lipid rafts:red, Epo-
R:green, DAPI/Hoechst:blue. Right panel is a merged image showing lipid raft and Epo-R co-localization (yellow). UT7 cells are shown in rows 1 and 2,
while human primary burst forming units are shown in rows 3 and 4, followed by a maturing, enucleated erythroid precursor in row 5. (B) Three
dimensional rendering of UT7 cells either untreated (left) or after Epo treatment (right). Top two rows display isosurfacing of the rafts (red), Epo-R
(green), and nucleus (Dapi, blue). Dapi was removed from the middle row to further visualize association of the receptor with rafts in the second row
of panels. The bottom row displays volume rendering of the same cells to illustrate membrane colocalization (yellow). (C) Quantitation of
colocalization in human primary erythroid cells. Values represent mean 6 SE. Immunofluorescence experiments were repeated at least 3 times,
representative micrographs provided.
doi:10.1371/journal.pone.0034477.g002
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which may serve to minimize the potential for ligand-independent
interaction with signaling intermediates. Upon growth factor
engagement, the receptor was recruited into lipid rafts accompa-
nied by the incorporation of signaling effectors necessary to
phosphorylate sites on the receptor tail and initiate signal
transduction, including both the JAK2 and Lyn kinases, in
addition to the principal downstream transcription factor, STAT5
(Fig. 3). Interestingly, CD45, a transmembrane protein tyrosine
phosphatase that serves to extinguish receptor signaling by
dephosphorylating JAK2 and the Epo-R, was constitutively
localized within membrane rafts in unstimulated cells, whereas
upon stimulation with Epo, re-partitioned exclusively into non-raft
fractions. These dynamic changes in CD45 partitioning should
serve to optimize receptor signaling upon ligand engagement,
while restricting the potential for ligand-independent effector
activation in the absence of the growth factor. Moreover, these
ligand induced changes in the redistribution of the Epo-R and its
effectors appear necessary for erythropoietin signal fidelity.
Disruption of rafts by cholesterol depletion abrogated Epo-
induced STAT5 phosphorylation in both UT7 cells and normal
erythroid precursors (Figs. 4–5), whereas non-receptor initiated
activation of MAPK by PMA remained intact. Intercalation of
membrane cholesterol by nystatin treatment also attenuated Epo
signaling, indicating that receptor integration into rafts is critical
and perhaps obligatory for Epo-R signaling.
The subcellular mechanisms responsible for ligand induced
changes in raft and receptor dynamics may involve G-protein
controlled cytoskeletal changes. The dependence of Epo-R
signaling on lipid raft recruitment and assembly is analogous to
the changes observed in lymphocytes after ligation of the T-cell or
B-cell receptors [19]. Within minutes of ligand engagement of the
T-cell receptor, receptor subunits translocate into lipid rafts from
their residence in non-raft membrane domains (Figure 3B). T-cell
receptor re-distribution is controlled by G-protein coupled actin
polymerization [19] involving activation of Rac GTPases,
a hematopoietic specific member of the Rho superfamily that
regulates the organization, dynamics and function of the actin
cytoskeleton [27]. Conditional knock-out of Rac2 was recently
shown to block early stages of erythropoiesis in the bone marrow
in murine models, suggesting that Rac2 may be a candidate
molecular regulator of the observed Epo-induced changes in
membrane dynamics [28,29]. Our studies show that inhibition of
either Rac1 or RhoA GTPases suppresses EpoR translocation into
membrane raft domains. Defects in GTPase activation therefore
Figure 3. Epo stimulation recruits signal effectors into raft fractions. (A) Raft fractions (R) were separated from non-raft fractions (NR) and
immunoblotted for Epo-R to investigate receptor translocation into rafts after Epo stimulation. Corresponding quantitation represents the mean 6 SE
of two independent experiments using four different Epo-R antibodies. (B) Raft fractions were isolated after stimulation with Epo at the indicated
time points and immunoblotted for Epo-R. Results show that EpoR is recruited into rafts within 1 minute of Epo stimulation reaching maximum
loading at 10 minutes, followed by gradual redistribution thereafter. Accompanying graphic quantitation of the representative experiment. (C) UT7
cells were starved overnight then treated with Epo for 10 min. After fractionation, the non-raft (NR) fractions and raft (R) fractions were pooled and
immunoblotted for the indicated proteins. (D) Activated forms of Jak2, STAT5, and MAPK were also increased in the raft fractions after Epo
stimulation. All westerns were repeated at least in duplicate.
doi:10.1371/journal.pone.0034477.g003
Epo-R Signaling Is Membrane Raft Dependent
PLoS ONE | www.plosone.org 5 April 2012 | Volume 7 | Issue 4 | e34477
could adversely affect receptor signaling in select pathologic
conditions. In myelodysplastic syndromes, for example, Rac
activation is impaired in neutrophils and CD34+ progenitors
[30], accompanied by impaired lipid raft formation and
a corresponding reduction in the generation of reactive oxygen
species after fMLP stimulation in granulocyte-macrophage colony-
stimulating factor primed neutrophils [31]. Abnormalities in raft
assembly in erythroid progenitors might also underlie the
previously described abnormalities in Epo-R signaling in MDS
which warrants further investigation [32]. Overall, our findings
indicate that ligand engagement of the Epo-R initiates dynamic
changes in raft assembly and composition that bring the receptor
and its effectors into spacial and temporal proximity within
a discrete membrane compartment that facilitates activation of the
signaling cascade. Development of strategies that enhance raft
assembly and Epo-R incorporation may be an attractive strategy
to improve erythropoiesis in hematologic disorders with impaired
erythropoietic response.
Materials and Methods
Reagents and Antibodies
CD71:APC, P-STAT5(Y694):PE, and CD45:FITC conjugated
antibodies used for flow cytometry and anti-CD45 used for
western blotting were all purchased from BD Biosciences (San
Jose, CA). STAT5, Lyn, Akt, P-Jak2, and Jak2 antibodies were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The
principal Epo-R antibody used in this study was purchased from
Santa Cruz Biotechnology (M-20). To confirm immuno-specificity
of Epo-R localization (Fig. 3A) we also included Abcam mouse
mAb (MM-0031-6G7), Abcam goat polyclonal, and Amgen
(Thousand Oaks, CA) A82 Epo-R antibodies. ROCK inihibitor,
Y-27632 dihydrochloride monohydrate, cholera toxin B (CTB)
HRP conjugate, methyl-beta-cyclodextran, Nystatin, and PMA
were purchased from Sigma-Aldrich (St. Louis, MO). P-MAPK,
MAPK, and anti-P-STAT5(Y694) for westerns were purchased
from Cell Signaling Technology (Danvers, MA). P-Akt, Alexa
FluorH 488 goat anti-rabbit IgG, and VybrantH Lipid Raft
Labeling Kit were ordered from Invitrogen (Carlsbad, CA).
Recombinant human Epo (Epo) was purchased from Stemcell
Technologies (Vancouver, BC, Canada). Rac1 Inhibitor was
purchased from EMD Millipore (Billerica, MA).
Cell Lines and Bone Marrow Cultures
The human leukemic cell line, UT7, was obtained from ATCC
(Gaithersburg, MD). UT7 cells were maintained in a-MEM
medium supplemented with 20% fetal bovine serum (FBS), 1%
penicillin/streptomycin solution, and 5 ng/ml GM-CSF. UT7/
Epo cells were maintained in IMDM medium supplemented with
10% FBS, 1% penicillin/streptomycin solution, and 1 U/mL Epo.
After overnight starvation, cells were stimulated with Epo at
a concentration of 3 U/mL. For Rac1 and ROCK inhibitor
experiments, cells were pretreated for 1 h with 100 nM and
100 uM, respectively, before stimulation with Epo. Low-density
mononuclear cell (MNC) fractions were isolated from heparinized
bone marrow aspirates from healthy volunteers purchased from
Lonza Walkersville Inc. (Walkersville, MD) using standard density
gradient centrifugation over Ficoll-Paque Plus (GE Healthcare,
Little Chalfont, United Kingdom), followed by washing and
resuspension in Iscove’s Modified Dulbecco Medium (IMDM)
Figure 4. Raft integrity is necessary for Epo-induced signaling. (A) UT7 cells were starved for 2 h then pretreated with MBCD for 30 min and
stimulated with 3 U/ml Epo for 10 min; lysates were immunoblotted with the indicated antibodies. (B) UT7/Epo cells were starved for 2 h then
pretreated with MBCD for 30 min and stimulated with 3 U/ml Epo for 10 min. Lysates were immunoblotted with P-Akt. The findings show abrogation
of Akt phosphorylation following MBCD pretreatment. (C) UT7 cells were pretreated with MBCD for 30 min, then stimulated with PMA for 30 min. (D)
UT7 cells were starved for 2 h then pretreated with Nystatin for 30 min and stimulated with Epo for 10 min. Immunoblots for phospho-STAT5, STAT5,
and b-actin antibodies with densitometry analysis. All westerns are representative of at least 2 independent experiments.
doi:10.1371/journal.pone.0034477.g004
Epo-R Signaling Is Membrane Raft Dependent
PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e34477
supplemented with 10% fetal bovine serum, penicillin, and
streptomycin.
Erythroid progenitors at the burst-forming unit–erythroid
(BFU-E) stage of differentiation were grown in cytokine-defined
IMDM, similar to previous studies [33]. Briefly, 26105 MNC per
mL were plated in Complete MethocultH medium (StemCell
Technologies, Vancouver, BC, Canada) supplemented with 10%
FBS and 3 U/mL erythropoietin. Plates were incubated at 37uC
in a 5% CO2 air mixture in a humidified incubator for 14 days.
BFU-E were identified using an inverted microscope, aspirated by
pipette, washed twice in PBS then resuspended in IMDM for
immunofluorescence studies.
Immunoblotting
Cells were starved in 0.5% FBS containing medium for 2 h
prior to 30 min pre-incubation with 10 mM MBCD or 50 mg/ml
nystatin, or stimulation with 3 U/ml Epo (10 min) or 100 ng/ml
PMA (30 min). For RAC and ROCK inhibitor experiments, cells
were pretreated for 1 h prior to Epo stimulation. Cells were
washed 36 in cold PBS and lysed in 16RIPA buffer containing
250 mM NaVO4, 2 mg/ml aprotinin, 2 mg/ml leupeptin, 0.2 mg/
ml pepstatin A, and 500 mM PMSF. Sample buffer was added to
cell lysates and 100 mg of protein was separated using SDS-PAGE.
Proteins were transferred to PVDF membranes and immuno-
blotted with the indicated antibodies. Membranes were developed
using ECL or ECL Plus according to manufacturer’s protocols
(GE Healthcare, Piscataway, NJ).
Flow Cytometry
Bone marrow from a normal donor was purchased from Lonza
(Walkersville, MD). BM-MNCs were isolated using Ficoll-Paque
PLUS (GE Healthcare, Piscataway, NJ) and starved for 2 h in
0.5% FBS containing IMDM medium. The cells were then
pretreated with 10 mM MBCD for 30 min and stimulated with
3 U/ml Epo for 10 min. They were immediately washed 36 in
cold Staining Buffer (BD Biosciences San Jose, CA), fixed for
10 min at 37uC in Cytofix (BD), then permeabilized for 30 min on
ice with Perm Buffer III (BD). Cells were stained with CD71:APC,
CD45:FITC, and P-STAT5:PE conjugated antibodies. Cells were
washed with Staining Buffer and analyzed on a FACScalibur flow
Figure 5. Cholesterol depletion attenuates Epo-induced STAT5 phosphorylation in primary erythroid progenitors. (A) Bone marrow
mononuclear cells from a normal donor were isolated then stained with CD71:APC, CD45:FITC, and P-STAT5:PE. CD71Hi/CD45dim cells representing
erythroid progenitors were gated. (B) Graphic comparison of geometric mean florescence intensities, mean 6 standard error from 3 independent
experiments. (C) Representative flow histogram showing shift in phospho-STAT5 florescence intensity in primary erythroid progenitors treated with
Epo with or without MbCD.
doi:10.1371/journal.pone.0034477.g005
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cytometer. Primitive erythroid cells were captured in CD71Hi and
CD45Dim gated population.
Lipid Raft Isolation
Lipid Rafts were isolated as previously described [11,31].
Briefly, UT7 cells were washed 26 with cold PBS then lysed in
0.75% Triton X-100 in TNE Buffer [TNE buffer composed of
25 mM Tris pH7, 150 mM EDTA, 1 mM DTT, 150 mM NaCl,
and 1 Complete EDTA-free protease inhibitor tablet from Roche
(Indianapolis, IN) per 20 ml buffer]. Cells were passed through
a 27G needle several times and incubated on ice for 5 min. Two
hundred microliters of lysate were mixed with 400 mL of 60%
Optiprep (Sigma-Aldrich, St. Louis, MO) and pipetted into an
ultracentrifuge tube. Decreasing percentages of Optiprep (35%,
30%, 25%, 20%, and 0%) were loaded on top of each other and
the tubes were spun at 20000 rpm for 20 h in a Beckman Coulter
(Fullerton, CA) Optima L-90K ultracentrifuge. Fractions were
pipetted off one by one and used for dot and western blotting.
Dot Blots
Five or ten microliters of fractionated cell lysates were pipetted
directly onto nitrocellulose membrane. The membranes were
allowed to dry then washed briefly in PBS. They were then
blocked in 0.3% Tween20 PBS for 30 min and incubated in
cholera toxin B:HRP conjugated antibody overnight. The blots
were washed 36 in 0.3% Tween20 PBS and developed with ECL.
Immunofluorescence
Starved UT7 cells (0.5% FBS supplemented a-MEM medium)
were stained with VybrantH Lipid Raft Labeling Kit according to
manufacturer’s protocol, treated with 3 U/ml EPO for 10 min at
37uC and fixed with Cytofix (BD Biosciences San Jose, CA) for
10 m at 37uC. Cells were then cytospun and stained with Epo-R
antibody at a 1:50 dilution for 1 hr at 37uC, washed in PBS and
stained 1:500 with Alexa FluorH 488 goat anti-rabbit IgG for 1 hr
at 37uC. Cells were then mounted using ProLongH AntiFade
reagent with DAPI (Invitrogen, Carlsbad, CA) and cover slip
placed on top. Micrographs were taken using a Leica TCS SP5
AOBS Laser Scanning Confocal microscope (Leica Microsystems,
Germany). BFU-E colonies isolated from progenitor cultures from
a normal donor were washed 26 then starved in 0.5% FBS
supplemented IMDM medium for 2 h. They were then stained
with Epo-R and Alexa FluorH 488 goat anti-rabbit IgG as above.
The cells were then washed and stained with VybrantH Lipid Raft
Labeling Kit according to manufacturer’s protocol. Cells were
resuspended in 1 ml medium and stained with 1 mg/ml Hoechst
stain (Invitrogen, Carlsbad, CA). Micrographs of the untreated
cells were taken by confocal microscopy then 3 U/ml of Epo was
added to the plate and micrographs from stimulated cells were
taken 5–20 min after Epo treatment.
Immunofluorescence Image Analysis
Photomicrographs were obtained using a Leica TCS SP5
AOBS laser scanning confocal microscope at zoom through
a 206/0.5NA or 636/1.40NA Plan Apochromat oil immersion
objective lens (Leica Microsystems, Germany). 405 Diode, Argon
488, and HeNe 543 or 594 laser lines were applied to excite the
flurophores and tunable emissions were used to minimize crosstalk
between fluorochromes. Gain, offset, and pinhole settings were
identical for all samples within the treatment group. Image
Figure 6. Recruitment of Epo-R into lipid rafts is dependent on Rac1 and RhoA GTPase activation. (A) Raft fractions were isolated from
UT7 cells pretreated with 100 nM Rac1 inhibitor for 1 hr prior to Epo stimulation then immunoblotted for Epo-R with corresponding quantitation. (B)
Raft fractions were isolated from UT7 cells pretreated with 100 uM ROCK inhibitor (Y-27632) for 1 h prior to Epo stimulation then immunoblotted for
Epo-R with corresponding densitometry analysis. Westerns are representative of two independent experiments.
doi:10.1371/journal.pone.0034477.g006
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sections were collected at either 0.2 mm (for 3D reconstructions) or
at 0.5 mm were captured with photomultiplier detectors and
maximum projections were prepared with the LAS AF software
version 2.1.0 (Leica Microsystems, Germany). In some cases, 46
zoom was applied when acquiring images. Intensity and aggregate
analysis were performed using Image Pro Plus version 6.2 (Media
Cybernetics, Inc., Silver Springs, Maryland). Identical threshold
settings and measurement parameters were used to generate the
mean intensity and area data. Aggregates were defined as an
object within the cell that has an intensity value of at least 20 and
an area between 3 and 600 pixels. Three dimensional isosurface
renderings were prepared with Imaris software version 5.5.3
(Bitplane Inc., Zurich, Switzerland).
Statistical analysis
Numerical data are expressed as mean 6 standard error of the
mean. Statistical analyses were performed using the Student t test
(2-tailed for equal variances). P values,0.05 were considered
significant. Pearson’s correlation analysis for colocalization was
performed using Definiens Developer version 1.5 (Definiens AG,
Munich, Germany).
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